Top Markets
Coin of the day
IGEA Pharma N.V. IGEA Pharma N.V.

IGEA Pharma N.V.

IGPH
Rangering i aksjer #40706
IGEA Pharma N.V. specializes in marketing health and medical technology... IGEA Pharma N.V. specializes in marketing health and medical technology products and devices across the United States and the Netherlands. Its product portfolio features Alz1, a home-based diagnostic kit for measuring non-bound copper in the bloodstream, alongside Alz1 Tab dietary supplements formulated to decrease heavy metal levels in the blood. The company also offers a rapid test for COVID-19, which identifies IgM and IgG SARS-CoV-2 antibodies. Additionally, it provides dry aerosol generators for sanitizing air and inanimate surfaces, as well as equipment for air purification and sterilization. The company also performs laboratory analysis services. Founded in 2015, IGEA Pharma N.V. maintains its primary offices in Hoofddorp, the Netherlands.
Aksjekurs
$0.00057292
Sist synkronisert: 2023-12-04
Markedsverdi
$95.08K
Endring (1 dag)
0.59%
Endring (1 år)
0.00%
Land
NL
Handel IGEA Pharma N.V. (IGPH)

Kategori

P/B-forhold for IGEA Pharma N.V. (IGPH)
P/B-forhold per 2026 TTM: 0
Ifølge IGEA Pharma N.V. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for IGEA Pharma N.V. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
4.0441 -
US
2.6166 -
US
- -
CN
21.3575 -
US
28.7765 -
US